15
Participants
Start Date
August 18, 2021
Primary Completion Date
May 31, 2027
Study Completion Date
March 31, 2028
NeoVax
It stimulates the immune system to attack cancer cells.
Cyclophosphamide
It is a chemotherapy drug used to treat many cancers. At low doses, it is an investigational drug to help the immune cells to be better at attacking cancer cells while avoiding chemotherapy toxicity.
Pembrolizumab
Is a monoclonal antibody that helps the immune cells to be better at attacking cancer cells.
RECRUITING
Dana-Farber Cancer Institute, Boston
Collaborators (2)
Oncovir, Inc.
INDUSTRY
BioNTech SE
INDUSTRY
Merck Sharp & Dohme LLC
INDUSTRY
Dana-Farber Cancer Institute
OTHER